Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0001
0.0000
(0.00%)
As of March 3 at 3:00:00 PM EST. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| Currency in USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.41 | -0.43 | -0.39 | -0.43 |
| EPS Actual | 0.19 | -2.97 | -0.42 | -0.55 |
| Difference | 0.6 | -2.54 | -0.03 | -0.12 |
| Surprise % | 146.34% | -590.70% | -7.69% | -27.91% |
EPS Trend
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NTBLQ | -- | -- | -- | -- |
| S&P 500 | 16.04% | 7.30% | 10.63% | 14.23% |
Upgrades & Downgrades
| Downgrade | JMP Securities: Market Outperform to Market Perform | 9/20/2024 |
| Maintains | Chardan Capital: Buy to Buy | 5/16/2024 |
Related Tickers
ETBI Eastgate Biotech Corp.
0.0045
+4,400.01%
MDCLF MedinCell S.A.
6.98
0.00%
ATHXQ Athersys, Inc.
0.0000
0.00%
HOPHF Hemogenyx Pharmaceuticals Plc
1.2400
0.00%
ELDN Eledon Pharmaceuticals, Inc.
3.8300
-4.37%
DMAC DiaMedica Therapeutics Inc.
5.90
-4.99%
SCPX Scorpius Holdings, Inc.
0.1443
-9.74%
RZLT Rezolute, Inc.
3.9750
-3.99%
PULM Pulmatrix, Inc.
7.08
-9.11%
ATHE Alterity Therapeutics Limited
3.5700
-1.92%